| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 05/29/2003 | US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 05/29/2003 | US20030100552 Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions |
| 05/22/2003 | WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 05/22/2003 | US20030096806 For use as pesicides, herbicides; crop protection |
| 05/22/2003 | US20030096000 Encapsulation of nanosuspensions in liposomes and microspheres |
| 05/21/2003 | EP1311498A1 Diamino phenothiazine derivatives and composition comprising same |
| 05/15/2003 | WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/14/2003 | CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
| 05/13/2003 | US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 05/08/2003 | WO2003037852A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 05/08/2003 | US20030087914 Citric acid salt of 4-(3,4-dichlorophenyl)-2-(2-(4-methylpiperazin-1-yl)-benzylidene) -thiomorpholin-3-one; serotonin receptor antagonists |
| 05/08/2003 | CA2464727A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 05/07/2003 | EP0889863B1 Surface modified carbonate materials |
| 05/07/2003 | EP0730738B1 Metal chelate containing compositions for use in chemiluminescent assays |
| 05/06/2003 | US6559145 Heterocycle carboxamides as antiviral agents |
| 05/06/2003 | US6559142 Tricyclic substituted cyclic sulfonamides compound is useful for treating heart disease, multiple sclerosis, arthritis, atherosclerosis, and osteoporosis |
| 05/02/2003 | EP1305292A1 Biphenyl carboxamides |
| 05/01/2003 | WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE |
| 05/01/2003 | US20030083333 1,4-Disubstituted benzo-fused compounds |
| 05/01/2003 | US20030083332 N-heterocyclic derivatives as NOS inhibitors |
| 04/29/2003 | US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery |
| 04/24/2003 | WO2003033481A1 Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 04/24/2003 | WO2003033456A1 NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
| 04/24/2003 | US20030078256 Serotonin receptor antagonist; treating cardiovascular disorder |
| 04/24/2003 | CA2463686A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/24/2003 | CA2463685A1 Novel .beta.-phenyl-.alpha.-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 04/24/2003 | CA2462442A1 Alkyne matrix metalloproteinase inhibitors |
| 04/23/2003 | EP1303500A1 Heterocyclic fluoroalkenyl thioethers (ii) |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | CN1413200A Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide |
| 04/22/2003 | US6552203 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups |
| 04/17/2003 | WO2003031458A1 Methods for synthesis of diarylmethanes |
| 04/17/2003 | WO2003031422A1 Novel benzothiazine derivatives, their preparation and use |
| 04/17/2003 | US20030073684 Respiratory system disorders; cardiovascular disorders; hemorrhage therapy |
| 04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/17/2003 | US20030073669 N-heterocyclic derivatives as NOS inhibitors |
| 04/17/2003 | CA2458388A1 Novel benzothiazine derivatives, their preparation and use |
| 04/16/2003 | EP1301493A2 Heterocycle carboxamides as antiviral agents |
| 04/15/2003 | US6548666 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them |
| 04/10/2003 | US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives |
| 04/10/2003 | US20030066988 Electroconductivity coloring |
| 04/09/2003 | EP1299366A1 Method for producing a phenothiazine granulate with improved properties |
| 04/08/2003 | US6545150 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 04/03/2003 | WO2003026563A2 Conjugated anti-psychotic drugs and uses thereof |
| 04/03/2003 | US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis |
| 04/03/2003 | CA2461663A1 Conjugated anti-psychotic drugs and uses thereof |
| 04/02/2003 | EP1165087A4 In vivo stain compounds and methods of use to identify dysplastic tissue |
| 04/02/2003 | EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 04/02/2003 | EP0912512B1 Sulphonamide derivatives and their use in the treatment of cns disorders |
| 04/02/2003 | CN1407977A (Hetero) aryl-substituted heterocyclic enaminones, production therof and use thereof as herbicides, acaricides and insecticides |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 03/27/2003 | WO2003024944A1 An improved process for the preparation of bicyclic antidiabetic compounds |
| 03/27/2003 | WO2003024941A1 Naphthalene compounds and use thereof as drugs |
| 03/27/2003 | WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | US20030060452 N-heterocyclic derivatives as NOS inhibitors |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/26/2003 | EP1294704A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 03/20/2003 | US20030055076 Novel compounds, their preparation and use |
| 03/20/2003 | US20030054200 Organic electroluminescence device |
| 03/20/2003 | US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials |
| 03/19/2003 | CN1403448A Process for producing 2-(4-alkyl-1-piperazyl)-benzaldehyde and-benzal compound |
| 03/18/2003 | US6534500 Use of cyamemazine in the treatment of abrupt benzodiazephine withdrawal |
| 03/13/2003 | WO2003020323A1 Light-stabilized $i(in vivo) stain composition and method of manufacture |
| 03/13/2003 | CA2458613A1 Light-stabilized in vivo stain composition and method of manufacture |
| 03/12/2003 | EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 03/12/2003 | EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 03/12/2003 | EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/11/2003 | US6531464 Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives |
| 03/05/2003 | EP1288208A1 Process for the preparation of 2-(4-Alkyl-1-Piperazinyl)-Benzaldehyde and -Benzylidenyl compounds by Nucleophilc Aromatic Substitution of 2-Fluorobenzaldehyde with 4-Alkyl-1-Piperazine in Water as Solvent |
| 03/05/2003 | CN1102595C Penems and their derivatives |
| 02/28/2003 | CA2399970A1 Process for the preparation of 2-(4-alkyl-1-piperazinyl)-benzaldehyde and -benzylidenyl compounds |
| 02/27/2003 | WO2003016294A1 Process for preparing sultams |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/18/2003 | WO2002018356A1 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 02/18/2003 | CA2419838A1 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 02/13/2003 | WO2003011834A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 02/13/2003 | US20030032801 Phenothiazine or iminodibenzyl derivatives as antimalarial agents |
| 02/13/2003 | US20030032635 Heterocyclic esters and amides |
| 02/12/2003 | EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/05/2003 | CN1394857A Compound used as antiproliferative agent and glycinamide ribonucleotide transformylase inhibitor |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/04/2003 | US6514990 Pharmaceutically active compounds and methods of use |
| 01/30/2003 | WO2003008398A1 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2003 | US20030023087 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 01/30/2003 | CA2453633A1 Aryl substituted thiazolidinones and the use thereof |
| 01/29/2003 | EP0835243B1 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/28/2003 | US6511942 Animal husbandry, veterinary medicine |
| 01/21/2003 | US6509335 This invention discloses benzoxazinone and benzothiazinone compounds which display inhibitory effects on serine proteases such as factor Xa, thrombin, and/or factor VIIa. The invention also discloses pharmaceutically acceptable salts of |
| 01/16/2003 | US20030013847 Pyruvate derivatives |